GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N95019C00007THE MCLEAN HOSPITAL CORPORATION

Overview

Award facts

Net obligations
$6.25M
$6,249,115of $6.25M potential value
Outlays (paid to date)
$3.37M
$3.37M paid of $6.25M obligated$3,374,537
Period of performance
Dec 13, 2018 to Dec 15, 2023
Ended
Modifications
13
Latest action Sep 9, 2025
Contract type
Definitive contract
PIID 75N95019C00007

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. BASE AWARD.

Dates and value

Award date
Signed on Dec 13, 2018
Potential end of performance
Dec 14, 2023
Current value
$6,249,115Base and exercised options
Potential value (if all options are exercised)
$6,249,115

Obligations by fiscal year of action

  • FY2025: -$983,419 (de-obligation)
  • FY2024: -$386,563 (de-obligation)
  • FY2023: $1,557,246
  • FY2022: $1,536,547
  • FY2021: $1,515,044
  • FY2020: $1,299,418
  • FY2019: $1,710,842

Total across 7 fiscal years: $6,249,115

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 9, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationBELMONT, MA
UEIMCKWJYCWNVN3
CAGE code1F6D4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded from
National institute on drug abuse (0893)Program activities075-0893Federal accounts (agency financial reports)

Place of performance

Place of performance
Belmont, Middlesex County, Massachusetts 02478-1064
Congressional district (place of performance)
MA-05As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
1

Solicitation and notices

Solicitation ID
NIHDA201800198(as reported)

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Assessment of potential substance abuse treatment medications in nonhuman primate models
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Dec 13, 2018Base obligation at award: $915,428
Latest action
Sep 9, 2025 — Funding onlyModification P00013; obligation change -$983,419; funding only: changes obligations, not scope
Latest substantive action
Dec 14, 2022 — Option exercisedModification P00011; obligation change +$1,557,246
Latest funding action
Sep 9, 2025 — Funding onlyModification P00013; obligation change -$983,419; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Option exercised9
  • Funding only2
  • Other administrative action2
14 actions recorded, Dec 13, 2018 to Sep 9, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$983,419
Latest action: change in base and all options
-$983,419

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
14

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950
Treasury accounts
  • 075-2019/2019-0893-000
  • 075-2020/2020-0893-000
  • 075-2021/2021-0893-000
  • 075-2022/2022-0893-000
  • 075-2023/2023-0893-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression